Young Women and Ovarian Suppression

Learn about the findings from the Suppression of Ovarian Function Trial (SOFT) which found that adding ovarian suppression to adjuvant exemestane (Aromasin) or to tamoxifen significantly lowered premenopausal women’s risk of recurrence. Hear how these findings may impact your care and explore questions to ask your doctor when considering ovarian suppression.